Fiona Boak
Optometrist · Louisville, KYNPI 1013045491
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $6,509 of the $7,509 with a category attached, or 86.7%. 14 manufacturers reported payments, led by Alcon at 33.2% of the total. Reporting peaked in 2022 at $2,149 and has fallen 64.4% since, to $765 in 2025. Among optometrist clinicians in KY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 95 payments — averaging $79.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$2K
- Bausch & Lomb Americas Inc.$2K
- Bausch & Lomb, A Division Of Bausch Health US, LLC$759
- Coopervision Inc.$422
- Johnson & Johnson Vision Care, Inc.$372
- AbbVie$252
- plus $761 from 8 others
What the payments were for
- Speaking & faculty fees$1,00013%
- Food & beverage$6,50987%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 28 | $2,492 |
| Bausch & Lomb Americas Inc. | 23 | $2,450 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 13 | $759 |
| Coopervision Inc. | 4 | $422 |
| Johnson & Johnson Vision Care, Inc. | 12 | $372 |
| AbbVie | 5 | $252 |
| Genentech, Inc. | 1 | $122 |
| Genentech USA, Inc. | 1 | $122 |
| Astellas Pharma US Inc | 1 | $120 |
| Oyster Point Pharma, Inc. | 1 | $120 |
| Aerie Pharmaceuticals, Inc. | 1 | $117 |
| GSK | 1 | $107 |
| Biotissue Holdings Inc. | 3 | $41 |
| Novartis | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INFUSE$2,053
- Precision 1$1,111
- Dailies Aqua Comfort Plus$1,000
- DAILIES TOTAL1$1,000
- Air Optix plus HydraGlyde$1,000
- AIR OPTIX$1,000
- TOTAL30$246
- Rhopressa$244
- Rocklatan$244
- MyDay Contact Lens$226
- BIOTRUE ONE DAY$226
- ReSTOR$136
- SIMBRINZA$127
- INFUSE MULTIFOCAL$124
- BIOTRUE$124
- ULTRA$124
- SUSVIMO$122
- VABYSMO$122
- Precision7$122
- TYRVAYA$120
How this compares
$7,509 in reported general payments places this provider in the 95th percentile of 712 optometrist providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Latanoprost | 41 | $469 |
| Prednisolone Acetate | 14 | $375 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 15 | $210 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Louisville
- Lee PeplinskiLouisville$74K
- Austin LifferthLouisville$72K
- Aaron McNultyLouisville$22K
- Ian McWherterLouisville$18K
- Kevin SnipesLouisville$13K
- Richard ManganLouisville$12K
- Keith SlaydenLouisville$9K
- Benjamin PaxtonLouisville$8K
- Nikolaos ZagorianosLouisville$8K
- Rod RalloLouisville$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.